Tao Sheng
About Tao Sheng
Tao Sheng is a Senior Manager of Biostatistics at BeiGene in the New York City Metropolitan Area, with a strong background in biostatistics and pharmaceuticals.
Company
Tao Sheng is currently employed at BeiGene as a Senior Manager in Biostatistics. BeiGene is an innovative global biotechnology company that focuses on molecularly targeted and immuno-oncology drug discovery. Tao is based in the New York City Metropolitan Area, leveraging his expertise in biostatistics to support the company's endeavors.
Title
Tao Sheng holds the title of Senior Manager, Biostatistics at BeiGene. In this role, he specializes in the application of biostatistical methods to support pharmaceutical development and clinical trials, ensuring the integrity and reliability of data analysis in the drug discovery process.
Education and Expertise
Tao Sheng has an extensive educational background that includes a PhD in Biostatistics from Rutgers University, which he achieved after five years of study from 2013 to 2018. He also holds a Master of Arts in Statistics from UC Santa Barbara, which he completed from 2011 to 2013. Additionally, Tao obtained a Bachelor of Science in Computer Science and Mathematics from Saint Louis University, where he studied from 2007 to 2011. His academic training has equipped him with proficiency in statistical software like R, SAS, and Python.
Professional Background
Tao Sheng's professional journey in biostatistics began with a four-year internship at Sanofi in Bridgewater, NJ, where he worked from 2014 to 2018. Following this, he served as a Senior Statistician at Sanofi for three years until 2021. During 2021, he briefly held the position of Clinical Modeling Project Lead for six months at Sanofi in Bridgewater, New Jersey. Throughout these roles, he developed robust skills in statistical modeling and data analysis within the pharmaceutical industry.
Research and Industry Focus
Tao Sheng has cultivated a strong research background within the pharmaceutical industry, primarily focusing on biostatistics. His professional endeavors encompass the application of advanced statistical methods to the design and analysis of clinical trials. His expertise in this specialized field significantly contributes to the development and approval of new medical treatments.